Table I.
Test | Disease detected |
---|---|
Anti-nuclear antibody | Systemic Lupus Erythematosus and other autoimmune diseases |
Anti-Smith antibody | Systemic Lupus Erythematosus |
Anti-dsDNA antibody | Systemic Lupus Erythematosus |
Complement C3 Complement C4 |
Systemic Lupus Erythematosus (low in active disease) |
Anti-Centromere antibody | Scleroderma |
Anti-Scl70 antibody | Scleroderma |
Anti-ribonuclear protein (RNP) | Mixed connective tissue disease |
SSA and SSB antibodies | Sjogrens Syndrome |
Rheumatoid Factor | Rheumatoid Arthritis |
Anti-Cyclic Citrullinated Peptide | Rheumatoid Arthritis |
Anti-neutrophil cytoplasmic antibodies | Granulomatosis with polyangiitis, Microscopic Polyangiitis, Eosinophilic granulomatosis with polyangiitis, Cocaine and Levamisole associated vasculitis |
Anti-β2-glycoprotein I antibodies | Antiphospholipid syndrome |
Anti-cardiolipin antibodies | Antiphospholipid syndrome |
Lupus Anticoagulant | Antiphospholipid syndrome |
Prothrombin gene mutation | Genetic prothrombotic state |
Factor-V Leiden mutation | Genetic prothrombotic state |
Plasminogen Activator Inhibitor | Genetic prothrombotic state |
MTHFR mutation | Genetic prothrombotic state |
Quantiferon gold | Tuberculosis exposure |
HIV test | HIV |
Hepatitis B and C | Hepatitis B and C |